Navigation Links
New Compound Offers Hope In Liver Cancer Treatment

The identification of a novel compound, CDDO-Im, shown to possess strong anti-tumor properties in studies conducted on animal models could soon revolutionize the treatment of liver cancer patients. // The compound has been found to increase the intrinsic resistance to carcinogens (cancer causing substances) by enhancing the function of enzymes that remove toxins from the body. Further results about the compound have been published in the journal Cancer Research.

The compound has been found to be active (100 times effective than other anti-tumor compounds) at very small doses. It is hoped that the compound could play an important role in the prevention of cancers associated with inflammation such as lung cancer, liver cancer, prostate cancer and gastric cancer. It can also help in the treatment of asthma, emphysema or other neurodegenerative disorders, linked to inflammation.

The synthetic compound, a derivative of oleanolic acid, belongs to a class of compounds commonly referred to as triterpenoids. Previous studies have established the anti-tumor properties of oleanolic derivatives in animals and humans.

In order to assess the effectiveness of cancer prevention, the researchers treated rats with aflatoxin, a carcinogen, known to cause liver cancer. The rates were treated with 0.1, 0.3, 1.0, 3.0 or 10 micromole doses of CDDO-Im. As much as 85% reduction in the incidence of pre-cancerous lesions could be observed when rats were treated with 0.1 mmol of the compound. This anti-cancer property could be due to associated activation of Nrf2 protein. This protein is believed to play a major role in the protection of body against environmental toxins.

The results of this study have several important clinical applications. First, it could lead to the development of new cancer prevention strategies. Second, it can attenuate the clinical features and provide relief to those suffering from inflammatory diseases. Third, it can pro tect humans from several diseases that can be attributed to a specific environmental agent.


'"/>




Related medicine news :

1. Compound of Broccoli combats breast cancer
2. New Compound Could Strengthen The Effect Of Chemotherapy
3. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
4. Compound from cottonseed for neck and head cancers
5. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
6. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
7. Compound In Grapes And Red Wine To Counter Alzheimers Disease
8. Sugars Could Contain Key Cancer Inhibiting Compounds
9. Compound From Cyanobacterium Can Fight Alzheimer’
10. Five New Anti-Inflammatory Compounds Produced By Indian Scientists
11. Compounds in Licorice Can Fight Tooth Decay
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/24/2017)... ... September 24, 2017 , ... “Star of Bethlehem Study”: is a thought-provoking ... the creation of published author, Duane Engdahl, an investigator who had has a long ... Duane Engdahl’s new book is a thought-provoking essay an event so significant that it ...
(Date:9/23/2017)... ... September 23, 2017 , ... Silicon Valley Hair Institute, the ... a new blog post focused on the ARTAS® hair transplant system and the younger ... to the latest, most technologically sophisticated methods of hair restoration. , “It can be ...
(Date:9/22/2017)... ... September 22, 2017 , ... On Sunday, September 24, hundreds ... honoring Olympian, Florence Joyner, still considered the fastest woman of all time. Flo ... daughter, Mary Joyner, will sing the National Anthem. Mary was a contestant on ...
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor , a construction ... Architect (RPA), a full-service architecture firm focusing on sustainable design, have announced ... Model Homes . Independently, Ecocor and RPA have extensive experience with site-built and ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, California, ... Leadership and Administration at St. Thomas University in Miami, Florida, was selected from ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... Va. , Aug. 29, 2017 ivWatch, LLC, the ... peripheral IV infiltrations, announced it has been awarded an Innovative Technology ... company in the country. ... continuous monitoring device to aid in the early detection of peripheral ... The Innovative ...
Breaking Medicine Technology: